刘晓程毕业于中国医学科学院心血管病研究所，曾赴澳大利亚查理王子医院进修。1987年到东北边城牡丹江创建了我国第二所心血管病专科医院。期间他培养了一批心血管领域的专业人才，为来自23个省的3000多位患者做了心脏手术。1992年7月，他在6天中连续为两位晚期心脏病患者进行了心脏移植手术；同年12月，完成了我国首例心肺移植手术。1994年奉调回京，先后担任中国医学科学院中国协和医科大学副院校长、党委书记。在此期间，刘晓程在北京协和医院创建心脏外科，同时作为国家“七五”攻关“冠状动脉搭桥术”主要组织和参与者，在全国率先开展全动脉化冠状动脉搭桥手术，治愈了大量先、后天疑难心脏病症。2001年刘晓程辞去了所有官职，来到天津经济技术开发区创建泰达国际心血管病医院。作为医院管理者，他锐意进取，积极探索公有制医院的管理新体制，使这所国内唯一参照现代企业制度运营的公有制医院，在体制改革、治理结构、用人制度、文化建设、服务社会诸方面为我国公有制医院改革开了先河；作为心血管外科专家，他医术精湛，医德高尚，全身心为心脏病患者服务，救治了大量的中外心血管病患者。

刘晓程自2009年起带领泰心医院医学团队与中国运载火箭技术研究院工学团队联合在国内最早开展第三代人工心脏——植入式磁液悬浮心室辅助装置的研究。植入该装置的实验羊“天久”健康存活120天，曾创下了国内最长存活记录。2019年，刘晓程带领团队将该装置植入两名终末期心衰患者体内，及时挽救了他们的生命。刘晓程作为该装置临床试验项目的主要研究者带领全国11家医院共同圆满完成50例临床试验，产品于2022年7月获国家药品监督管理局批准上市，已挽救百余名晚期心衰患者。更新一代的人工心脏产品已经完成研发和制造，并进入动物实验阶段。

刘晓程曾任《中国心血管病研究》编委会主任等职，在各类期刊发表论文180余篇，其中核心期刊152篇，近10年发表SCI论文30余篇。他参与多项国家科技部、天津市科委项目，如重大心脏病有关生物标记物的产品研发及临床应用、中国人冠心病的遗传学等，其科研项目“内皮-平滑肌功能调节机制及其在心血管外科相关的基础研究”获中华医学科技奖三等奖。他致力于新技术的临床实际应用和转化，不断进行创新和研发，获得包括“低速高压心肌打孔器”在内的多项国家发明专利和实用新型专利。

国务院授予刘晓程“全国先进工作者”称号，他连续两次被聘请出任国务院深化医药卫生体制改革专家咨询委员会委员；国家教委和人事部联合授予他“有突出贡献的回国留学人员”；国家人事部授予他“国家级有突出贡献的中青年专家”称号；国家卫生部授予他“全国卫生系统优秀留学回国人员”、“全国卫生文明建设先进工作者”称号；他还被英国剑桥国际传记中心收入《有成就的人》、《国际传略词典》、《国际知识分子名人录》和《大洋洲和远东名人录》；美国北卡罗莱纳国际传记中心将其列入《世界5000人》、《国际杰出领导名录》和《500名有影响的领导者》等国际传略文献。包括新华社、《人民日报》海外版、香港《大公报》、《文汇报》在内的多家国内外新闻媒体曾多次报道过他的事迹；中央电视台《东方时空》、《神州风采》、《中华学人》栏目也曾对他进行讨专题报道；中央电视台为他拍摄了电视专题片《求索》和《脊梁》；天津电影制片厂曾以他为生活原型拍摄了故事片《归国留学生》。

到泰达创业，他奋斗不息，相继于2005年在“感动泰达20年20人”评选中被中共天津开发区工委、管委会授予特别荣誉奖；2006年荣获中共天津开发区工委授予的“开发区行业领军人物”称号；2007年荣获中华全国总工会授予的“全国五一劳动奖章”；2009年获得国家民政部授予的“全国优秀公益人物”称号；2010年由柬埔寨国王诺罗敦·西哈莫尼签发、参议院主席谢辛亲王颁发、中国驻柬埔寨大使潘广学见证，授予刘晓程院长“柬埔寨王国国家大护卫特级荣誉勋章”，成为第二位获此殊荣的中国公民；2011年荣获中国医院协会授予的“全国优秀医院院长”称号；2011年荣获天津市总工会授予的“天津市最有影响力劳模”；2014年荣获中国医院协会授予的“全国医院管理突出贡献奖”；2018年荣获健康报主办的“第十届健康中国总评榜年度人物”称号；2019年获得由中共中央、国务院、中央军委颁发的“庆祝中华人民共和国成立70周年”纪念章。

XiaoCheng Liu

Name：XiaoCheng Liu（President）

Specialty：Cardiovascular Surgery

Title：Chief Physician

Degree：Master

Dr. Liu XiaoCheng professor, chief surgeon and PhD. supervisor of Cardiovascular Surgery serves as the president of TEDA (Tianjin Economic-Technological Development Area) International Cardiovascular Hospital (TICH) and the Dean of Cardiovascular College of Tianjin Medical University. His concurrent society posts are Member of Healthcare Reform Advisory committee of the State Council of China, Standing Member of Chinese Medical Association (CMA), standing member of Chinese Hospital Association (CHA), Vice-President of Tianjin Medical Association, member of American Association for Thoracic Surgery (AATS), International Member of The Society of Thoracic Surgeons (STS), Fellow of Eisenhower Fellowship of USA and visiting professor of Tokyo Medical and Dental University. In recognition of his contribution to China’s medical society, State Education Commission & Ministry of Personnel awarded him “National Distinguished Scientist with Outstanding Contribution Who has Studied in Abroad”, Ministry of Personnel awarded him “National Distinguished Young and Middle Aged Scientist”, The State Council entitled him “All-China Model Worker”, and Ministry of Public Health granted him “National Outstanding Person in Medicine Who has Studied in Abroad”.

Dr. Liu took advanced cardiovascular surgery fellowship at The Prince Charles Hospital in Australia in 1984. Three years later, he volunteered to relocate from Beijing to Mudanjiang, a remote city in Northeast China and set up Mudanjiang Cardiovascular Hospital, the second professional cardiovascular hospital in China, where he conducted more than 3000 open-heart surgeries for the patients from 23 provinces including two heart transplant operations within six days and the first heart--lung transplant in China. Since 1994, Dr. Liu had been the vice-president of CAMS and PUMC. Meanwhile, he founded the Department of Cardiovascular Surgery of PUMC Hospital and became the first to conduct coronary revascularization with total arterial conduits in China.

Pursuing his dream of establishing a new public hospital management model in China, Dr. Liu left from his leadership posts in Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) in 2000 and founded TEDA International Cardiovascular Hospital in Tianjin Economic-Technological Development Area (TEDA). Without any conventional administrative rankings or staffing of government-affiliated institutions, TICH adopted a series of modern cybernetics-based management systems, such as the contract employment policy. The vitality brought by this new model, which is completely consistent with the state healthcare reform plan, make the patient-oriented operation systems into being. By rendering better services to the public, the hospital has won larger space and greater speed for its sustainable development.

Over the past twelve years since opening, TICH has performed more than 90,000 open-heart surgical cases and interventional cardiovascular procedures, for the patients from all over China and also from USA, UK, Japan, Canada, Germany, Russia, Qatar and Cambodia. Among of them, there are not only more than 8000 orphans and children in poverty suffering from congenital heart diseases, but also Hollywood movie star and even some Cambodia national leader. The hospital has been accredited three-times the gold seal of Joint Commission International (JCI) and twice JCI CCPC certificates (AMI and Heart Failure), being the first and unique hospital in China to earn three gold medals of JCI. After 4 years of joint research with China Academy of Launch Vehicle Technology (CALT), TICH has invented the third-generation Ventricular Assist Device (VAD)—Magnetic-Hydrodynamic Suspension Bearing Centrifugal Blood Pump, which has reached the advanced international level, enjoys complete independent intellectual property right as well as the first one of its type in China. The sheep installed with third-generation VAD walk freely with the lithium cells and console, completely identical to the actual clinical implantation.

In acknowledge of his contribution to China Healthcare development, The State Education Commission & The Ministry of Personnel jointly awarded him “National Distinguished Scientist with Outstanding Contribution”, The Ministry of Personnel awarded him “National Young and Middle Aged Scientist with Distinguished Contribution”, The State Council entitled him “All China Model Worker”, and The Ministry of Public Health granted him “National Outstanding Healthcare Worker Trained in Abroad” and “National Outstanding Healthcare Worker”. His story was collected into “Men of Achievement”, “Dictionary of International Biography” by International Biography Centre (Cambridge, UK) and “5000 Personalities of The World”, “The International Directory of Distinguished Leadership”, “and Five Hundred Leaders of Influence” by American Biography Institute (NC, USA). “People Daily, Oversea Version”, “Hong Kong Dogongbao”, “Wenhuibao”, and many other domestic and foreign Medias have reported his stories for hundreds of times. “Oriental Horizon”, “Chinese Elegancy” and “Chinese Scholars” of CCTV also made exclusive TV interview to him. CCTV produced documentary “Exploration” and “Back Bone” to praise his contribution. Tianjin Film Studio produced film of “Back to motherland”, based on his real stories.

Dr. Liu continues his new career in TEDA. He was awarded special prize of “Twenty People Move TEDA in Twenty Years” in 2005; “Leading People of TEDA & Tianjin Free Trade Zone” in 2006; “National Labor Medal” in 2007; “National Excellent Charity Person” in 2009 and so on. On June 2nd 2010, His Excellency, Chairman of Congress of Cambodia, Samdech Chea Sim granted him the Medal of Royal Order of Kingdom of Cambodia Class" Mohasena" appointed by the King of Cambodia Norodom Sihamoni in Phnom Penh, becoming the second Chinese citizen awarded the medal of Royal Order.

“Love & Help”, the hospital motto original from Dr. Liu, is not only a cordial self-encourage, but also a solemn commitment to the society. He is determined to lead us continually on the way of reform healthcare looking forward to the arrival of spring in medical field of China.